Skip to content
Disclosery

Finepoint Capital LP

Follow

13F filer, CIK 1608126, BOSTON, MA

Finepoint Capital LP reported $2,003,633,201 across 9 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-13.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000904454-26-000098

Period
2025-12-31
Reported value
$2B
Holdings
9
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RXOadded+2,121,950$26.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
QXOreduced-1,118,200-$21.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0000904454-26-000098, largest first. % of portfolio is the value over $532,795,937, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
QXOQXO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,750,781 shares; 2024Q4: 24,933,825 shares; 2025Q1: 24,468,160 shares; 2025Q2: 21,152,868 shares; 2025Q3: 22,295,615 shares; 2025Q4: 21,177,415 shares 21,177,415$409M76.67%-1,118,200Timeline
RXORXO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 7,266,839 shares; 2025Q4: 9,388,789 shares 9,388,789$119M22.27%+2,121,950Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 961,251 shares; 2024Q4: 961,251 shares; 2025Q1: 961,251 shares; 2025Q2: 961,251 shares; 2025Q3: 961,251 shares; 2025Q4: 961,251 shares 961,251$5.42M1.02%0Timeline
ANNAALEANNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 27,717 shares; 2025Q1: 27,717 shares; 2025Q2: 27,717 shares; 2025Q3: 27,717 shares; 2025Q4: 27,717 shares 27,717$79K0.01%0Timeline
ANNAWALEANNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 490,000 shares; 2025Q1: 490,000 shares; 2025Q2: 490,000 shares; 2025Q3: 490,000 shares; 2025Q4: 490,000 shares 490,000$69.3K0.01%0Timeline
MNYWWMONEYHERO LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 895,000 shares; 2024Q4: 895,000 shares; 2025Q1: 895,000 shares; 2025Q2: 895,000 shares; 2025Q3: 895,000 shares; 2025Q4: 895,000 shares 895,000$38.3K0.01%0Timeline
CLDICALIDI BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,042 shares; 2025Q4: 1,042 shares 1,042$1.22K<0.01%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SPYSTATE STR SPDR S&P 500 ETF T SHSput1,573,200$1.07B+365,700
IWMISHARES TR SHSput1,617,000$398M0

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000904454-26-000098 base2026-02-13acceptance time not in the bulk data set